| AEs of interest | Other AEs | SAEsa | ||||
|---|---|---|---|---|---|---|
| Patients, n (%) (N = 125) |
AEs, n | Patients, n (%) (N = 125) |
AEs, n | Patients, n (%) (N = 125) |
AEs, n | |
| Any AE | 16 (12.8) | 23 | 19 (15.2) | 26 | 5 (4.0) | 5 |
| Severity of AEb | ||||||
| Mild | 11 (8.8) | 14 | 10 (8.0) | 13 | 0 | 0 |
| Moderate | 5 (4.0) | 8 | 6 (4.8) | 10 | 1 (0.8) | 1 |
| Severe | 1 (0.8) | 1 | 3 (2.4) | 3 | 4 (3.2) | 4 |
| AEs considered related to Ig20Gly | ||||||
| Related | 7 (5.6) | 8 | 3 (2.4) | 4 | 0 | 0 |
| Possibly related | 5 (4.0) | 7 | 4 (3.2) | 4 | 1 (0.8) | 1 |
| Probably related | 2 (1.6) | 2 | 2 (1.6) | 2 | 0 | 0 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.